KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Non-Current Assets (2016 - 2026)

West Pharmaceutical Services has reported Non-Current Assets over the past 18 years, most recently at $2.3 billion for Q1 2026.

  • Quarterly Non-Current Assets rose 5.66% to $2.3 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $9.1 billion through Mar 2026, up 8.72% year-over-year, with the annual reading at $2.3 billion for FY2025, 8.86% up from the prior year.
  • Non-Current Assets was $2.3 billion for Q1 2026 at West Pharmaceutical Services, roughly flat from $2.3 billion in the prior quarter.
  • Over five years, Non-Current Assets peaked at $2.3 billion in Q4 2025 and troughed at $1.6 billion in Q3 2022.
  • The 5-year median for Non-Current Assets is $1.9 billion (2024), against an average of $2.0 billion.
  • Biggest five-year swings in Non-Current Assets: rose 2.52% in 2022 and later increased 19.19% in 2024.
  • Tracing WST's Non-Current Assets over 5 years: stood at $1.7 billion in 2022, then increased by 11.54% to $1.9 billion in 2023, then increased by 11.21% to $2.1 billion in 2024, then increased by 8.86% to $2.3 billion in 2025, then fell by 0.38% to $2.3 billion in 2026.
  • According to Business Quant data, Non-Current Assets over the past three periods came in at $2.3 billion, $2.3 billion, and $2.3 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.